The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial

The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial

Background: Biologic agents used in patients with inflammatory bowel diseases (IBD) may influence the pathophysiology of coexistent metabolic-dysfunction associated steatotic liver disease (MASLD). This study primarily aimed to evaluate the six-month effect of infliximab or vedolizumab vs. no biolog...

Full description

Saved in:
Bibliographic Details
Main Authors: Apostolis Papaefthymiou (Author), Styliani Sarrou (Author), Konstantinos Pateras (Author), Ilias D. Vachliotis (Author), Georgios Agrotis (Author), Ioanna-Konstantina Sgantzou (Author), Georgios Perifanos (Author), Andreas Kapsoritakis (Author), Matthaios Speletas (Author), Marianna Vlychou (Author), George N. Dalekos (Author), Spyros Potamianos (Author), Antonis Goulas (Author), Jannis Kountouras (Author), Stergios A. Polyzos (Author)
Format: Book
Published: MDPI AG, 2024-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items